Tapewire

Nasdaq · USD

TMDX

TransMedics Group, Inc.

Export transactions ↓
Tapewire entity
4261
SEC CIK
0001756262
Parsed reports
356

Last 12 months

Inside the activity.

2 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202511
Dec 202502
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 24, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 1,976 $50.22 $99,234.72
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.72, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 24, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 1,976 $2.21 $4,366.96
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 24, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 2,514 $50.18 $126,152.52
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 24,776

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.72, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 24, 2022 Filed Aug 25, 2022 21:00 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 3,591 $50.13 $180,016.83
Disclosure

SEC source: 0000899243-22-029754 · doc4.xml · nonDerivative · entry 2

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 466,285

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 8,024 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · derivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,027

Underlying: Common Stock · 8,024 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F6 · derivative.exercise_date: The option is fully vested.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 7,486 $50.04 $374,599.44
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 27,290

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 8,024 $50.04 $401,520.96
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.16, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 17:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 8,024 $2.21 $17,733.04
Disclosure

SEC source: 0000899243-22-029753 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 21:00 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 16,409 $50.04 $821,106.36
Disclosure

SEC source: 0000899243-22-029754 · doc4.xml · nonDerivative · entry 1

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 469,876

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 12, 2022 Filed Aug 15, 2022 21:50 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 7,000 $48.00 $336,000.00
Disclosure

SEC source: 0000899243-22-028660 · doc4.xml · nonDerivative · entry 2

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 486,285

F1 · kind: Represents a sale of shares of common stock to generate cash for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of certain equity-based awards or the exercise of stock options as permitted by the lock-up agreement, dated August 3, 2022, among the Reporting Person, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Cowen and Company, LLC as the representatives of the underwriters named therein.

Read SEC document
August 11, 2022 Filed Aug 15, 2022 21:50 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 12,929 $46.74 $604,301.46
Disclosure

SEC source: 0000899243-22-028660 · doc4.xml · nonDerivative · entry 1

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 493,285

F1 · kind: Represents a sale of shares of common stock to generate cash for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of certain equity-based awards or the exercise of stock options as permitted by the lock-up agreement, dated August 3, 2022, among the Reporting Person, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Cowen and Company, LLC as the representatives of the underwriters named therein.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $46.39 to $47.26, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 08, 2022 Filed Aug 9, 2022 22:00 UTC
Gordon StephenChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-028140 · doc4.xml · derivative · entry 3

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,728

Underlying: Common Stock · 10,000 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
August 08, 2022 Filed Aug 9, 2022 22:00 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 10,000 $48.09 $480,900.00
Disclosure

SEC source: 0000899243-22-028140 · doc4.xml · nonDerivative · entry 2

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,714

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $48.01 to $48.79, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 08, 2022 Filed Aug 9, 2022 22:00 UTC
Gordon StephenChief Financial Officer
Exercise / conversionCommon Stock 10,000 $2.21 $22,100.00
Disclosure

SEC source: 0000899243-22-028140 · doc4.xml · nonDerivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 18:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-028141 · doc4.xml · derivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,051

Underlying: Common Stock · 10,000 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 18:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 10,000 $45.08 $450,800.00
Disclosure

SEC source: 0000899243-22-028141 · doc4.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 34,776

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $45.00 to $45.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 18:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 10,000 $45.16 $451,600.00
Disclosure

SEC source: 0000899243-22-028141 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 18:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 10,000 $2.21 $22,100.00
Disclosure

SEC source: 0000899243-22-028141 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 22:00 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 20,000 $45.13 $902,600.00
Disclosure

SEC source: 0000899243-22-028142 · doc4.xml · nonDerivative · entry 1

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,214

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $45.00 to $45.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · derivative · entry 10

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,784

Underlying: Common Stock · 3,000 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F8 · derivative.exercise_date: The option is fully vested.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
SaleCommon Stock 400 $41.84 $16,736.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 7

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 771

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $41.78 to $41.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
SaleCommon Stock 2,200 $41.39 $91,058.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 6

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,171

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.78 to $41.76, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
SaleCommon Stock 400 $40.02 $16,008.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 5

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,371

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.60 to $40.39, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 3,000 $2.21 $6,630.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 4

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
July 29, 2022 Filed Aug 1, 2022 20:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,823 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-027252 · doc4.xml · derivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,051

Underlying: Common Stock · 7,823 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
July 29, 2022 Filed Aug 1, 2022 20:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,681 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-22-027252 · doc4.xml · derivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,681 shares

Expires 2023-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
July 29, 2022 Filed Aug 1, 2022 20:30 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 13,504 $40.01 $540,295.04
Disclosure

SEC source: 0000899243-22-027252 · doc4.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,076

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 29, 2022 Filed Aug 1, 2022 20:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 7,823 $2.21 $17,288.83
Disclosure

SEC source: 0000899243-22-027252 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 29, 2022 Filed Aug 1, 2022 20:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 5,681 $0.28 $1,590.68
Disclosure

SEC source: 0000899243-22-027252 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 00:30 UTC SaleCommon Stock 48,515 $39.98 $1,939,629.70
Disclosure

SEC source: 0000899243-22-027253 · doc4.xml · nonDerivative · entry 1

TOBIN JAMES R · CIK 0001190128 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By the James R. Tobin 2012 Trust

Disclosed balance after: 253,591

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.90 to $40.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 1,959 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · derivative · entry 9

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,784

Underlying: Common Stock · 1,959 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F8 · derivative.exercise_date: The option is fully vested.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 2,041 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · derivative · entry 8

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,834

Underlying: Common Stock · 2,041 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F7 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
SaleCommon Stock 4,000 $40.01 $160,040.00
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 3

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 771

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 1,959 $2.21 $4,329.39
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 2

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 00:40 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 2,041 $13.28 $27,104.48
Disclosure

SEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

Read SEC document
July 20, 2022 Filed Jul 22, 2022 21:00 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 1,125 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000899243-22-026586 · doc4.xml · derivative · entry 5

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,875

Underlying: Common Stock · 1,125 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares.

Read SEC document
July 20, 2022 Filed Jul 22, 2022 21:00 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 375 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-22-026586 · doc4.xml · derivative · entry 4

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 375 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares.

Read SEC document
July 20, 2022 Filed Jul 22, 2022 21:00 UTC
Carey John FVP of Operations
SaleCommon Stock 1,500 $34.57 $51,855.00
Disclosure

SEC source: 0000899243-22-026586 · doc4.xml · nonDerivative · entry 3

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.50 to $34.71, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 20, 2022 Filed Jul 22, 2022 21:00 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 1,125 $13.28 $14,940.00
Disclosure

SEC source: 0000899243-22-026586 · doc4.xml · nonDerivative · entry 2

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 20, 2022 Filed Jul 22, 2022 21:00 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 375 $16.14 $6,052.50
Disclosure

SEC source: 0000899243-22-026586 · doc4.xml · nonDerivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 11, 2022 Filed Jul 12, 2022 21:27 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-22-025989 · doc4.xml · derivative · entry 3

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,625

Underlying: Common Stock · 1,500 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares.

Read SEC document
July 11, 2022 Filed Jul 12, 2022 21:27 UTC
Carey John FVP of Operations
SaleCommon Stock 1,500 $32.98 $49,470.00
Disclosure

SEC source: 0000899243-22-025989 · doc4.xml · nonDerivative · entry 2

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.60 to $33.49, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 11, 2022 Filed Jul 12, 2022 21:27 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 1,500 $16.14 $24,210.00
Disclosure

SEC source: 0000899243-22-025989 · doc4.xml · nonDerivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 18:17 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 13,504 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-22-025481 · doc4.xml · derivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,681

Underlying: Common Stock · 13,504 shares

Expires 2023-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 18:17 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 13,504 $35.06 $473,450.24
Disclosure

SEC source: 0000899243-22-025481 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,076

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.19, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 18:17 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 13,504 $0.28 $3,781.12
Disclosure

SEC source: 0000899243-22-025481 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 22:17 UTC SaleCommon Stock 48,515 $35.00 $1,698,025.00
Disclosure

SEC source: 0000899243-22-025482 · doc4.xml · nonDerivative · entry 1

TOBIN JAMES R · CIK 0001190128 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By the James R. Tobin 2012 Trust

Disclosed balance after: 302,106

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.90 to $35.12, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 22:19 UTC
Gordon StephenChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-025484 · doc4.xml · derivative · entry 3

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,728

Underlying: Common Stock · 10,000 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: The option is fully vested.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 22:19 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 10,000 $35.00 $350,000.00
Disclosure

SEC source: 0000899243-22-025484 · doc4.xml · nonDerivative · entry 2

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,714

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 22:19 UTC
Gordon StephenChief Financial Officer
Exercise / conversionCommon Stock 10,000 $2.21 $22,100.00
Disclosure

SEC source: 0000899243-22-025484 · doc4.xml · nonDerivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.